Effects of cholestyramine and parenteral nutrition on hepatic metabolism of lidocaine: A study using isolated rat liver perfusion

Journal of Parenteral and Enteral Nutrition

Volumn 20, Issue 5, 1996, Pages 349-356

  Zaman, Nuzhat ^a   Tam, Yun K ^a   Jewel, Lawrence D ^b   Coutts, Ronald T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Dept of Lab Medicine and Pathology ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; LIDOCAINE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; GLUCOSE INFUSION; HISTOPATHOLOGY; HYDROXYLATION; INTESTINE ABSORPTION; LIVER METABOLISM; LIVER PERFUSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL NUTRITION; PRIORITY JOURNAL; RAT; STEATOSIS;

EID: 0029835941     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607196020005349     Document Type: Article

References (84)

1. Fisher RL: Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol Clin N Am 18:645-666, 1989
2. Hodes JE, Grosfeld JL, Weber TR: Hepatic failure in infants on total parenteral nutrition (TPN): Clinical and histopathologic observations. J Pediatr Surg 17:463-468, 1982
3. Bell RL, Ferry GD, Smith EO: Total parenteral nutrition-related cholestasis in infants. JPEN 10:356-359, 1986
4. Allardyce DB: Cholestasis caused by lipid emulsion. Surg Gynecol Obstet 154:641-647, 1982
5. Sondheimer JM, Bryan H, Andrews M: Cholestatic tendencies in premature infants on and off parenteral nutrition. Pediatrics 62:984-989, 1978
6. Vileisis RA, Inwood RJ, Hunt CE: Prospective controlled study of parenteral nutrition associated cholestatic jaundice: Effect of protein intake. J Pediatr 96:893-897, 1980
7. Merritt RJ: Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr 5:9-22, 1986
8. Balistreri WF, Bove KE: Hepatobiliary consequences of parenteral alimentation. Prog Liver Dis 9:567-601, 1990
9. Grant JP, Cox CE, Kleinman LM: Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet 145:573-580, 1977
10. Keim NL: Nutritional effectors of hepatic steatosis induced by parenteral nutrition in the rat. JPEN 11:18-22, 1987
11. Keim NL, Mares-Perlman JA: Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat free parenteral nutrition. J Nutr 114:1807-1815, 1984
12. Farrell MK, Balistreri WF, Suchy FJ: Serum-sulfated lithocholate as an indicator of cholestasis during parenteral nutrition in infants and children. JPEN 6:30-33, 1982
13. Dorvil NP, Yousef IM, Roy CC: Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr 37:221-232, 1983
14. Yousef IM, Tuchweber B, Vonk RI: Lithocholate cholestasis-sulfated glycolithocholate-induced intrahepatic cholestasis in rats. Gasteroenterology 80:233-241, 1981
15. Fischer CD, Cooper NS, Rothchild MA: Effect of dietary chenodeoxycholic acid and lithocholic acid in the rabbit. Am Dig Dis 19:877-886, 1995
16. Miyai K, Richardson AL, Mayr W: Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. Lab Invest 36:249-258, 1977
17. Balistreri WF, Suchy FJ, Farrell MK, et al: Pathologic versus physiologic cholestasis: Elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease. J Pediatr 98:399-402, 1981
18. Hofmann AF: Chemistry and enterohepatic circulation of bile acids. Hepatology 4:4S-14S, 1984
19. Macdonald IA, Bokkenheuser VD, Winter J, et al: Degradation of steroids in the human gut. J Lipid Res 24:675-700, 1983
20. Chesney RW: Taurine: Its biological role and clinical implications. Adv Pediatr 32:1-42, 1985
21. Cooper A, Betts JM, Pereira GR, et al: Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J Pediatr Surg 19:462-465, 1984
22. Jarvenpaa AN, Rassin DK, Kuitunen P: Feeding the low-birth-weight infant. III. Diet influences bile acid metabolism. Pediatrics 72:677, 1983
23. Javitt NB: Cholestasis in rats induced by taurolithocholate. Nature 210:1262, 1966
24. Kakis G, Yousef IM: Pathogenesis of lithocholate and taurolithocholate induced intrahepatic cholestasis in rats. Gastroenterology 75:595-607, 1978
25. Layden TJ, Boyer JL: Taurolithocholate-induced cholestasis. Gastroenterology 73:120-128, 1977
26. Miyai K, Mayr YY, Richardson AL: Acute cholestasis induced by lithocholic acid in the rat: A freeze-fracture replica and thin section study. Lab Invest 32:527, 1975
27. Knodell RG: Effects of formula composition on hepatic and intestinal drug metabolism during enterai nutrition. JPEN 14:34-38, 1990
28. Einarsson K, Ericsson S, Ewerth S, et al: Bile acid sequestrants: Mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol 40:853-58, 1991
29. Ast M, Frishman WH: Bile acid sequestrants. J Clin Pharmacol 106:99-106, 1990
30. Gallo DG, Bailey KR, Shefner AL: The interaction between cholestyramine and drugs. Proc Soc Exp Biol Med 120:60-65, 1965
31. Benveniste C, Striberni R, Dayer P: Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam. Eur J Clin Pharmacol 38:547-549, 1990
32. Caldwell JH, Bush CA, Greenberger NJ: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. J Clin Invest 50:2638-2644, 1971
33. Eastwood GL: Failure of cholestyramine to prevent bile salt injury to mouse gastric mucosa. Gastroenterology 68:1466-1472, 1975
34. Poley JR, Caplan DB, Magnani HN, et al: Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease. Eur J Clin Invest 8:397-404, 1978
35. Ke J, Tam YK, Koo WWK, et al: Effects of parenteral nutrition on hepatic elimination of lidocaine: A study using the isolated perfused rat liver. J Pharmacol Exp Ther 255:351-356, 1990
36. Tam YK, Yau R, Bergins R: Mechanisms of lidocaine kinetics in the isolated perfused rat liver 1. Effects of continuous infusion. Drug Metab Dispos 15:12-16, 1987
37. Miller LL. Technique of isolated rat liver perfusion. IN Isolated liver perfusion and its applications, Bartosek I, Guaitani A, Miller LL (eds). Raven Press, New York, 1973, pp 11-52
38. Hussain MD, Tam YK, Gray MR, et al: Mechanisms of time-dependent kinetics of diltiazem in the isolated perfused rat liver. Drug Metab Dispos 22:36-42, 1994
39. Bloxam DL. Condition and performance of the rat liver perfused with Kreb's ringer solution, with particular reference to amino acid metabolism. IN Isolated liver perfusion and its applications, Bartosek I, Guaitani LL, Miller LL (eds). Raven Press, New York, 1973, pp 147-157
40. Gores GJ, Kost LI, LaRusso NF: The isolated perfused rat liver: Conceptual and practical considerations. Hepatology 6:511-517, 1986
41. Sedgwick GW, Fenton TW, Thopmson JR: Effect of protein precipitating agents on the recovery of plasma free amino acids. Can J Anim Sci 71:953-957, 1991
42. Osuga T, Mitamura K, Mashige F, et al: Evaluation of fluorimetrically estimated serum bile acid in liver disease. Clin Chim Acta 75:81-90, 1977
43. Nelson SD, Garland WA, Breck GD, et al: Quantification of lidocaine and several metabolites utilizing chemical-ionization mass spectrometry and stable isotope labeling. J Pharm Sci 66:1180-1190, 1977
44. Ngo LY, Tam YK, Coutts RT Lack of residual effects diethyl ether, methoxyflurane and sodium pentobarbital on lidocaine metabolism in a single-pass isolated rat liver perfusion system. Drug Metab Dispos 23:525-528, 1995
45. Saville BA, Gray MR, Tam YK: Evidence for lidocaine-induced inactivation. J Pharm Sci 78:1003-1008, 1989
46. SPSS for windows base system user's guide [computer program]. Norusis MJ. 5. SPSS Inc, Chicago, 1992
47. Montgomery DC: Nonparametric methods in the analysis of variance. IN Design and analysis of experiments. John Wiley and Sons, New York, 1991, pp 126-133
48. Guide to the care and use of experimental animals. 1. Canadian Council on Animal Care. Ottawa, 1984
49. Farkas P, Hyde D. The liver. IN Basic skills in interpreting laboratory data, Traub SL (ed). American Society of Hospital Pharmacists, Inc, Bethesda, 1992, pp 121-138
50. Knodell RG, Steele NM, Cerra FB: Effects of parenteral and enterai hyperalimentation on hepatic drug metabolism in the rat, J Pharmacol Exp Ther 229:589-597, 1984
51. Knodell RG, Spector MH, Brooks DA, et al: Alterations in pentobarbital pharmacokinetics in response to parenteral and enterai alimentation in the rat. Gasteroenterology 79:1211-1216, 1980
52. Ross LH, Griffeth L, Hall RI, et al: Hepatotoxic effects of parenteral nutrition upon in vivo pharmacokinetics of antipyrine. Surg Forum 34:34-36, 1983
53. Freund HR, Rimon B: Sepsis during total parenteral nutrition. JPEN 14:39-41, 1990
54. Wolf A, Pohlandt F: Bacterial infection: The main cause of acute cholestasis in newborn infants receiving short-term parenteral nutrition. J Pediatr Gastroenterol Nutr 8:297-303, 1989
55. Shu Z, Li J, Zhou Z, et al: Histopathologic study of cholestasis induced by total parenteral nutrition or intraperitoneal sepsis in rats. JPEN 15:630-636, 1991
56. Knodell RG, Wood DG, Guengerich FP: Selective alteration of constitutive hepatic cytochrome P-450 enzymes in the rat during parenteral hyperalimentation. Biochem Pharmacol 38:3341-3345, 1989
57. Oda Y, Imaoka S, Nakahira Y, et al: Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes. Biochem Pharmacol 38:4439-4444, 1989
58. Imaoka S, Enomoto K, Oda Y, et al: Lidocaine metabolism by human cytochrome P-450s purified from hepatic miorosomes: Comparison of those with rat hepatic cytochrome P450s. J Pharmacol Exp Ther 255:1385-1391, 1990
59. Knodell RG, Steele NM, Dannan G, et al: Alterations in turnover and isozyme pattern of cytochrome P-450 in rats receiving total parenteral nutrition. Clin Res 35:250, 1987
60. Carrells M, Ericsson S, Piano CD, et al: Effect of cholestyramine treatment on biliary lipid secretion rates in normolipidaemic men. J Int Med 229:241-246, 1991
61. Schachter D: Fluidity and function of hepatocytes plasma membranes. Hepatology 4:140-151, 1984
62. Gibson GG, Skett P. Enzymology and molecular mechanisms of drug metabolism reactions. IN Introduction to drug metabolism, Chapman and Hall Ltd, London, 1986, pp 39-81
63. Pandak WM, Vlahcevic ZR, Heuman DM, et al: Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 a-hydroxylase. Hepatology 19:941-947, 1994
64. Knodell RG, Whitmer DI, Holman RT: Influence of hyperalimentation on rat hepatic microsomal fluidity and function. Gasteroenterology 98:1320-1325, 1990
65. Bailey DN, Coffee JJ, Anderson B, et al: Interaction of tricyclic antidepressants with cholestyramine in vitro. Ther Drug Monit 14:339-342, 1995
66. Malloy MJ, Ravis WR, Pennell AT, et al: Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics. Int J Clin Pharmacol 32:286-289, 1994
67. Cohen MI: Changes in hepatic function. IN Intravenous nutrition in the high risk infant, Winters RW, Hasselmyer EG (eds). J Wiley and Sons, New York, 1975, pp 293-305
68. Burgess P, Hall RI, Bateman MD: The effect of total parenteral on hepatic drug oxidation. JPEN 11:540-543, 1987
69. Hartshorn RD, Demers LM, Sultatos LG: Effect of chronic parenteral carbohydrate administration on hepatic drug metabolism in the rat. Pharmacology 18:103-111, 1979
70. Heger J, Frydrych Z: Efficiency of utilization of amino acids. IN Absorption and utilization of amino acids, Friedman M (ed). CRC Press, Inc, Boca Raton, FL, 1989, pp 31-56
71. Pantuck EJ, Pantuck CB, Weissman C: Effects of parenteral nutrition regimens on oxidative drug metabolism. Anaesthesiology 60:534-536, 1995
72. Morgan ET, MacGeoch C, Gustafsson JA: Hormonal and developmental regulation of expression of the hepatic microsomal steroid 16-alpha-hydroxylase cytochrome P-450 apoprotein in the rat. J Biol Chem 260:11895-11898, 1985
73. Dannan GA, Guengrich FP, Waxman DJ: Hormonal regulation of rat liver microsomal enzymes: Role of gonadal steroids in programming, maintenance and suppression of delta-4-steroid 5-alpha reductase, flavin containing monooxygenase and sex specific cytochromes P-450. J Biol Chem 261:10728-10735, 1986
74. Fang WF, Strobel HW: Control by gastrointestinal hormones of the hydroxylation of the carcinogen benzo[a]pyrene and other xenobiotics in rat colon. Cancer Res 41:1407-1412, 1981
75. Farell G, Koltai A: Hepatic testosterone metabolism in male rats with portal bypass. Gasteroenterology 95:425-433, 1988
76. Farell GC, Koltai A, Zaluzny L: Effects of portal vein ligation on sex hormone metabolism in male rats: relationship to lowered hepatic cytochrome P450 levels. Gastroenterology 90:299-305, 1986
77. Johnson LR, Copeland EM, Dudrick SJ, et al: Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats. Gastroenterology 68:1177-1183, 1975
78. Zamir O, Nussbaum MS, Bhadra S, et al: Effect of enterai feeding on hepatic steatosis induced by total parenteral nutrition. JPEN 18:20-25, 1994
79. Greenberg GR, Wolman SL, Christofides ND, et al: Effect of total parenteral nutrition on gut hormone release in humans. Gasteroenterology 80:988-993, 1981
80. Lickley HLA, Track NS, Vranic M, et al: Metabolic responses to enterai and parenteral nutrition. Am J Surg 135:172-177, 1978
81. Ross LH, Griffeth L, Hall RI, et al: Elimination of hepatoxicity of total parenteral nutrition using fat-carbohydrate mixture. Surg Forum 35:97-99, 1984
82. Bhatia J, Rivera A, Moslen MT, et al: Hepatic function during short-term total parenteral nutrition: Effect of exposure of parenteral nutrients to light. Res Commun Chem Pathol Pharmacol 78:321-340, 1992
83. Goodgame JT, Lowry SF, Brennan MF: Body weight change and nutritional adequacy in the parenterally alimented rat. J Surg Res 24:520-526, 1978
84. Popp MB, Morrison SD, Brennan MF: Growth and body composition during long term total parenteral nutrition in the rat. Am J Clin Nutr 36:1119-1128, 1982